Navigation Links
Leukopenia in Medical News
Genetic Variation Associated With Survival Advantage in African Americans With HIV
... Duffy antigen receptor for chemokine (DARC) and leukopenia have slower HIV-to-AIDS progression rates than ... (WBC) counts than persons of European ancestry. leukopenia is one of several blood conditions observed ... is relatively unknown. "Even though leukopenia is tied to both African ancestry and faster ...... of patients with NSCLC were anemia (8 vs 7); leukopenia (5 vs 28); neutropenia (5 vs ... of patients with MPM were neutropenia (24 vs 4); leukopenia (16 vs 1); anemia (6 vs 0); thrombocytopenia (5 ... alone, respectively, were neutropenia (58 vs 16); leukopenia (55 vs 20); anemia (33 vs 14); thrombocytopenia ...
... of patients with NSCLC were anemia (8 vs 7); leukopenia (5 vs 28); neutropenia (5 vs ... of patients with MPM were neutropenia (24 vs 4); leukopenia (16 vs 1); anemia (6 vs 0); thrombocytopenia (5 ... alone, respectively, were neutropenia (58 vs 16); leukopenia (55 vs 20); anemia (33 vs 14); thrombocytopenia ...
New therapy with stem cells to treat Crohn's disease
... Initial Chemotherapy (Cyclophosphamide + G-CSF). In this initial phase, leukopenia or reduction of the number of leukocytes (immune-system cells) in the ... until ready for transplant. Second Chemotherapy. In this phase, total leukopenia is induced; that is, the immune system is left devoid of leukocytes, ready ...Novel therapeutic approaches may improve patient outcomes in several platelet disorders
... by 15 to 25 percent. Secondary objectives included safety, duration of leukopenia and thrombocytopenia, and the number of red blood cell transfusions. ... no life-threatening or fatal bleeding was reported. The duration of leukopenia and the need for red blood cell transfusions were the same in both arms. ...Gene Mutation Increases Drug Toxicity, Rejection Risk in Pediatric Kidney Transplants
... transferase. Adverse side effects most commonly linked to MMF have included gastrointestinal complications (such as diarrhea) or leukopenia - a drop in white blood cell count that can put patients at higher risk for infections. In some instances, patients have to be taken off the drug or ...Novel treatments show improvements in survival and response rates for leukemia and lymphoma
... in the FCR arm as compared with 62.3 percent in the FC arm. While FCR was found to cause more neutropenia (33.6 percent versus 20.9 percent) and leukopenia (24 percent versus 12.1 percent), it did not increase the incidence of severe infections (18.8 percent versus 14.8 percent) as compared with FC. ...... in the FCR arm as compared with 62.3 percent in the FC arm. While FCR was found to cause more neutropenia (33.6 percent versus 20.9 percent) and leukopenia (24 percent versus 12.1 percent), it did not increase the incidence of severe infections (18.8 percent versus 14.8 percent) as compared with FC. ...
... nausea (48% vs 28%), peripheral neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% vs 26%), lymphopenia (24% vs 17%), anorexia (23% vs 10%), asthenia (21% vs ...
... commonly occurring adverse reactions by SC route were nausea (70.5%), anemia (69.5%), thrombocytopenia (65.5%), vomiting (54.1%), pyrexia (51.8%), leukopenia (48.2%), diarrhea (36.4%), fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%), neutropenia (32.3%) and ecchymosis (30.5%). Other ...
Leukopenia in Medical Technology
... by 15 to 25 percent. Secondary objectives included safety, duration of leukopenia and thrombocytopenia, and the number of red blood cell transfusions.
... no life-threatening or fatal bleeding was reported. The duration of leukopenia and the need for red blood cell transfusions were the same in both arms.
...
... nausea (48% vs 28%), peripheral neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% vs 26%), lymphopenia (24% vs 17%), anorexia (23% vs 10%), asthenia (21% vs ...
... (48% vs 28%), peripheral neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% vs 26%), lymphopenia (24% vs 17%), anorexia (23% vs 10%), asthenia (21% vs ...
... insomnia; alopecia (hair loss); a reaction at the site of injection; changes in blood liver function tests and in blood cell counts, including leukopenia (low white blood cell count), thrombocytopenia (low platelet count) and neutropenia (low neutrophil count); thyroiditis (inflammation of the thyroid ...
... phosphatase (68%), elevated serum creatinine (57%), lymphopenia (53%), hypophosphatemia (49%), thrombocytopenia (40%), elevated AST (38%), and leukopenia (32%). Most common Grades 3/4 adverse events included asthenia (11%), dyspnea (9%), hemoglobin decreased (20%), lymphocytes decreased (16%), ...
... phosphatase (68%), elevated serum creatinine (57%), lymphopenia (53%), hypophosphatemia (49%), thrombocytopenia (40%), elevated AST (38%), and leukopenia (32%). Most common Grades 3/4 adverse events included asthenia (11%), dyspnea (9%), hemoglobin decreased (20%), lymphocytes decreased (16%), ...
... phosphatase (68%), elevated serum creatinine (57%), lymphopenia (53%), hypophosphatemia (49%), thrombocytopenia (40%), elevated AST (38%), and leukopenia (32%). Most common grades 3/4 adverse events included asthenia (11%), dyspnea (9%), hemoglobin decreased (20%), lymphocytes decreased (16%), glucose ...
... CINV is 24 hours to 120 hours following treatment.(8) The most commonly reported all-cause adverse events in the treatment arms were neutropenia, leukopenia and anemia, which occurred at a higher rate in the casopitant arms. The incidence of serious neutropenia adverse events was two percent in the active ...
... or life-threatening) adverse events were neutropenia (a decrease in the number of granular white blood cells, 54%); febrile neutropenia, 5.5%, leukopenia (low white blood cell count, 14%), and weakness/fatigue (10%; no Grade 4 events). Grade 3 peripheral neuropathy (a functional disturbance or damage ...
Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
... cisplatin for the treatment of patients with MPM were neutropenia (24%); leukopenia (16%); anemia (6%); thrombocytopenia (5%); infection without neutropenia ... with ALIMTA for the treatment of patients with NSCLC were anemia (8%); leukopenia (5%); neutropenia (5%); thrombocytopenia (2%); infection without ...... nausea (48% vs 28%), peripheral neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% vs 26%), lymphopenia (24% vs 17%), anorexia (23% vs 10%), asthenia (21% vs ...
... (48% vs 28%), peripheral neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% vs 26%), lymphopenia (24% vs 17%), anorexia (23% vs 10%), asthenia (21% vs ...
... insomnia; alopecia (hair loss); a reaction at the site of injection; changes in blood liver function tests and in blood cell counts, including leukopenia (low white blood cell count), thrombocytopenia (low platelet count) and neutropenia (low neutrophil count); thyroiditis (inflammation of the thyroid ...
... phosphatase (68%), elevated serum creatinine (57%), lymphopenia (53%), hypophosphatemia (49%), thrombocytopenia (40%), elevated AST (38%), and leukopenia (32%). Most common Grades 3/4 adverse events included asthenia (11%), dyspnea (9%), hemoglobin decreased (20%), lymphocytes decreased (16%), ...
... phosphatase (68%), elevated serum creatinine (57%), lymphopenia (53%), hypophosphatemia (49%), thrombocytopenia (40%), elevated AST (38%), and leukopenia (32%). Most common Grades 3/4 adverse events included asthenia (11%), dyspnea (9%), hemoglobin decreased (20%), lymphocytes decreased (16%), ...
... phosphatase (68%), elevated serum creatinine (57%), lymphopenia (53%), hypophosphatemia (49%), thrombocytopenia (40%), elevated AST (38%), and leukopenia (32%). Most common grades 3/4 adverse events included asthenia (11%), dyspnea (9%), hemoglobin decreased (20%), lymphocytes decreased (16%), glucose ...
... CINV is 24 hours to 120 hours following treatment.(8) The most commonly reported all-cause adverse events in the treatment arms were neutropenia, leukopenia and anemia, which occurred at a higher rate in the casopitant arms. The incidence of serious neutropenia adverse events was two percent in the active ...
... or life-threatening) adverse events were neutropenia (a decrease in the number of granular white blood cells, 54%); febrile neutropenia, 5.5%, leukopenia (low white blood cell count, 14%), and weakness/fatigue (10%; no Grade 4 events). Grade 3 peripheral neuropathy (a functional disturbance or damage ...
Leukopenia in Medical Dictionary
... leukopenia - An abnormally low white blood cell count. ... Slightly higher counts are seen in children. leukopenia : Lower than the normal amount of white blood ... For: search help Printer-Friendly Format ... leukopenia : An abnormally low number of white blood cells ...
... medications known to cause thrombocytopenia or leukopenia as a side effect. Note: Clinical trials ... by anorexia , diarrhea , loss of hair , leukopenia , thrombocytopenia , growth retardation , and ... ( anemia ), low white blood cell count ( leukopenia ) with a tendency to infection , and low ...
... that stimulates thyroid hormone production. pan immunity ; pan leukopenia ; pan leukopenia virus of cats; panlobular emphysema ; panmixis; panmyelophthisis; ...
... blood cells, the blood cells responsible for fighting infection . leukopenia ... Granular leukocytes -- they are better known as granulocyte s ... infections , inflammation of mammary glands , intestinal antiseptic, leukopenia (reduction in blood leukocytes ), ... identified to be correlated ...
... panic ulated; panic um; panidiomorphic; panidrosis; pan immunity ; pan leukopenia ; pan leukopenia virus of cats; panlobular emphysema ; panmixis; panmyelophthisis; ...
... in patients being treated for acute myelogenous leukemia . is characterized by low red blood cells ( anemia ), low white blood cell count ( leukopenia ) with a tendency to infection , and low platelet count ( thrombocytopenia ) with bleeding problems. MDS may progress and transform into acute ...
... Zantryl (ION Labor atories). Graft vs Host Disease - The clinical entity characterized by anorexia , diarrhea , loss of hair , leukopenia , thrombocytopenia , growth retardation , and eventual death brought about by the GRAFT VS HOST REACTION. Starving for Control: The Truth ...
... for pain relief during an attack. Graft vs Host Disease - The clinical entity characterized by anorexia , diarrhea , loss of hair , leukopenia , thrombocytopenia , growth retardation , and eventual death brought about by the GRAFT VS HOST REACTION. Gastrointestinal (e.g., ...
... extensive, but use of this drug is limited in the cancer population because of concern that it causes bone marrow suppression, in particular leukopenia . Other common adverse effects include nystagmus , dizziness , diplopia , ... ...
... elevations or bumps on the skin ) that may grow together to form plaques. eosinophil ic leukocyte; eosinophil ic leukocytosis; eosinophil ic leukopenia ; eosinophil ic lung disease ; eosinophil ic meningitis ; eosinophil ic meningo encephalitis ; eosinophil ic pneumonia ; eosinophil ic ...
... medications known to cause thrombocytopenia or leukopenia as a side effect. Note: Clinical trials ... by anorexia , diarrhea , loss of hair , leukopenia , thrombocytopenia , growth retardation , and ... ( anemia ), low white blood cell count ( leukopenia ) with a tendency to infection , and low ...
... that stimulates thyroid hormone production. pan immunity ; pan leukopenia ; pan leukopenia virus of cats; panlobular emphysema ; panmixis; panmyelophthisis; ...
... blood cells, the blood cells responsible for fighting infection . leukopenia ... Granular leukocytes -- they are better known as granulocyte s ... infections , inflammation of mammary glands , intestinal antiseptic, leukopenia (reduction in blood leukocytes ), ... identified to be correlated ...
... panic ulated; panic um; panidiomorphic; panidrosis; pan immunity ; pan leukopenia ; pan leukopenia virus of cats; panlobular emphysema ; panmixis; panmyelophthisis; ...
... in patients being treated for acute myelogenous leukemia . is characterized by low red blood cells ( anemia ), low white blood cell count ( leukopenia ) with a tendency to infection , and low platelet count ( thrombocytopenia ) with bleeding problems. MDS may progress and transform into acute ...
... Zantryl (ION Labor atories). Graft vs Host Disease - The clinical entity characterized by anorexia , diarrhea , loss of hair , leukopenia , thrombocytopenia , growth retardation , and eventual death brought about by the GRAFT VS HOST REACTION. Starving for Control: The Truth ...
... for pain relief during an attack. Graft vs Host Disease - The clinical entity characterized by anorexia , diarrhea , loss of hair , leukopenia , thrombocytopenia , growth retardation , and eventual death brought about by the GRAFT VS HOST REACTION. Gastrointestinal (e.g., ...
... extensive, but use of this drug is limited in the cancer population because of concern that it causes bone marrow suppression, in particular leukopenia . Other common adverse effects include nystagmus , dizziness , diplopia , ... ...
... elevations or bumps on the skin ) that may grow together to form plaques. eosinophil ic leukocyte; eosinophil ic leukocytosis; eosinophil ic leukopenia ; eosinophil ic lung disease ; eosinophil ic meningitis ; eosinophil ic meningo encephalitis ; eosinophil ic pneumonia ; eosinophil ic ...
Leukopenia in Biological News
Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants
... transferase. Adverse side effects most commonly linked to MMF have included gastrointestinal complications (such as diarrhea) or leukopenia a drop in white blood cell count that can put patients at higher risk for infections. In some instances, patients have to be taken off the drug or ...Eribulin mesylate demonstrated anti-tumor activity in patients with advanced breast cancer
... or life- threatening) adverse events were neutropenia (a decrease in the number of granular white blood cells, 54%); febrile neutropenia, 5.5%, leukopenia (low white blood cell count, 14%), and weakness/fatigue (10%; no Grade 4 events). Grade 3 peripheral neuropathy (a functional disturbance or damage ...Leukopenia in Biological Technology
... included: neutropenia (Grade 3/4: 54%) and leukopenia (Grade 3/4:
49%). (Phase III, Combination Trial: ... included: neutropenia (Grade 3/4: 68%) and leukopenia (Grade
3/4: 57%). Comparative treatment-related ... capecitabine alone
included: neutropenia 11% and leukopenia 6%. IMPORTANT SAFETY INFORMATION TOXICITY IN ...
... commonly occurring adverse reactions by SC route were nausea (70.5%), anemia (69.5%), thrombocytopenia (65.5%), vomiting (54.1%), pyrexia (51.8%), leukopenia (48.2%), diarrhea (36.4%), fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%), neutropenia (32.3%) and ecchymosis (30.5%). Other ...
... insomnia; alopecia (hair loss); a reaction at the site of injection; changes in blood liver function tests and in blood cell counts, including leukopenia (low white blood cell count), thrombocytopenia (low platelet count) and neutropenia (low neutrophil count); thyroiditis (inflammation of the thyroid ...
... one patient is too early to evaluate. There have been no episodes of Grade 4 (i.e., life-threatening) side-effects. Four patients experienced Grade 3 leukopenia (i.e., reduction in white blood cell count), and 1 patient had Grade 3 thrombocytopenia (i.e., reduction in platelet count). "Our goal with this ...
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
... (73%), diarrhea (72%), and nausea (55%). The most common grade 3/4 adverse events (greater than or equal to 10%) included: diarrhea (22%), leukopenia (17%), asthenia/malaise (16%), and acneform rash (14%) Important Safety Information for ALIMTA ALIMTA is approved by the FDA in combination with ...... commonly occurring adverse reactions by SC route were nausea (70.5%), anemia (69.5%), thrombocytopenia (65.5%), vomiting (54.1%), pyrexia (51.8%), leukopenia (48.2%), diarrhea (36.4%), fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%), neutropenia (32.3%) and ecchymosis (30.5%). Other ...
... insomnia; alopecia (hair loss); a reaction at the site of injection; changes in blood liver function tests and in blood cell counts, including leukopenia (low white blood cell count), thrombocytopenia (low platelet count) and neutropenia (low neutrophil count); thyroiditis (inflammation of the thyroid ...
... one patient is too early to evaluate. There have been no episodes of Grade 4 (i.e., life-threatening) side-effects. Four patients experienced Grade 3 leukopenia (i.e., reduction in white blood cell count), and 1 patient had Grade 3 thrombocytopenia (i.e., reduction in platelet count). "Our goal with this ...
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
... the most commonly occurring adverse reactions were nausea (70.5%), anemia (69.5%), thrombocytopenia (65.5%), vomiting (54.1%), pyrexia (51.8%), leukopenia (48.2%), diarrhea (36.4%), fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%), neutropenia (32.3%) and ecchymosis (30.5%). Other ...Other ContentsOther Tags
(Date:5/20/2013)... 2013 Gerald Wojtala, executive director of ... at North Carolina Food Safety and Defense Task Force’s ... Need for Partnerships – from Farm to Fork – ... for May 22-23 at the Sheraton Imperial Hotel, will ... sector have in protecting the food supply. , Wojtala ...
(Date:5/19/2013)... The special introductory offer for the ... soon. "We are so excited to introduce our serum ... Beauty®. "It is a pleasure to use, it is ... also moisturizes the skin. One of the powerful ingredients ... is very successful in clinical studies." , Collagen makes ...
(Date:5/19/2013)... the heterogeneity the variety of genetic mutations of ... patients with the most common type of head and neck ... Cancer , investigators at Massachusetts General Hospital (MGH) and ... a better predictor of survival than most traditional risk factors ... of the head and neck. , "Our findings ...
(Date:5/19/2013)... Alonso Krangle LLP a dedicated law firm , ... on behalf of a-24-year-old financial analyst rendered quadriplegic as a ... accident lawsuit, which was filed in the Supreme Court for ... the property out as a bathing beach, but posted absolutely ... No. 34556/12) , According to the diving accident lawsuit complaint, ...
(Date:5/19/2013)... The three surgeons from the Center for ... Abrutyn, M.D., Robert S. Boretz, M.D., and Thomas J. ... current location, 215 Union Avenue, Suite B, Bridgewater, N.J. ... medicine, with emphasis on injuries of the knee and ... for a wide range of orthopedic problems. Dr. Abrutyn's ...
Breaking Medicine News(10 mins):Health News:IFPTI Executive Director to Speak at North Carolina Food Safety and Defense Task Force Annual Conference 2Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 2Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 3Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 2Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 3Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 2Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 3[0] IFPTI Executive Director to Speak at North Carolina Food Safety and Defense Task Force Annual Conference[0] Collagen is a Key Anti-Aging Ingredient and is Featured in the New Collagen Peptide Serum at Sublime Beauty®; Introductory Offer on Now[0] Genetic diversity within tumors predicts outcome in head and neck cancer[0] Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach[0] Summit Medical Group Welcomes the Center for Orthopedic Care
(Date:5/17/2013)... The State University of New Jersey, and City University ... called Visikol TM that effectively clears organisms to ... place of chloral hydrate, which is one of the ... tightly regulated by the Drug Enforcement Administration (DEA) due ... or clearing agents, are vital for viewing organisms under ...
(Date:5/17/2013)... Sustainable Global Logistics Operations) is aiming to cut CO2 ... intermodal loading systems and the boosting of intelligent systems ... with experience in the logistics sector and in supply ... a duration of three and a half years. , ... components and ontologies shared by the users, objects and ...
(Date:5/16/2013)... Bethesda, MD (May 17, 2013) Illustrating a ... the American Gastroenterological Association (AGA) Research Foundation ... Future Student Research Fellowship Award recipients. Supported by ... Kidney Diseases (NIDDK), this new award helps underrepresented ... digestive disease and nutrition research. , "By establishing ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2VillusHbRatioHydratepneumoniaebygonorrhoeaepsittaciReflexiveCBCEsterifiedEpoxideQuantitiationjejuniAntibodyCAHOSHA
Other Tags| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |